General Information of DTT (ID: TTPKHTZ)

DTT Name Activin receptor type IB (ACVR1B) DTT Info
Gene Name ACVR1B

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
Investigative Drug(s)
6 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BDBM108945 DMZD6IJ N. A. N. A. Patented [1]
US10030004, Compound 11a DMG4T13 N. A. N. A. Patented [2]
US10030004, Compound 19 DM0RAPC N. A. N. A. Patented [2]
US10030004, Compound 33 DMD0GN6 N. A. N. A. Patented [2]
US9682983, 1 DM6EQVT N. A. N. A. Patented [1]
US9682983, 33 DM6R1YP N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Patented Agent(s)
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID23639540C13d DMSTQGH Discovery agent N.A. Investigative [3]
PMID23639540C13r DMHBZ0N Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 BMP inhibitors and methods of use thereof. US9682983.
2 Compounds and methods of use. US10030004.
3 Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52.